Organization
Ruhr-University Bochum, Herne
4 abstracts
Abstract
ANATOMICAL DISTRIBUTION OF MRI LESIONS IN axSpA AND DIFFERENCES BETWEEN PATIENTS WITH AND WITHOUT PERIPHERAL INVOLVEMENT: RESULTS FROM THE ASAS CLASSIFICATION COHORTOrg: University College London, Centre for Rheumatology, Division of Medicine, London, United Kingdom, Hacettepe University Cancer Institute, University of Alberta, Ruhr-University Bochum, Herne, Tel-Aviv University Medical School,
Abstract
ACHIEVEMENT OF REMISSION OF INFLAMMATION IN THE SPINE AND SACROILIAC JOINTS MEASURED BY MAGNETIC RESONANCE IMAGING (MRI) IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, AND ASSOCIATIONS BETWEEN MRI AND CLINICAL REMISSION, OVER 96 WEEKS OF TREATMENT WITH CERTOLOrg: Rheumazentrum Ruhrgebiet, Herne, Germany, Department of Medicine, University of Alberta, Alberta, Canada, Academic Medical Center Amsterdam & Atrium Medical Center, Heerlen, Netherlands, Ruhr-University Bochum, Herne, Charité Medical School, Berlin, Germany,
Abstract
BIMEKIZUMAB ACHIEVED SUSTAINED IMPROVEMENTS IN EFFICACY OUTCOMES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, REGARDLESS OF PRIOR TNF INHIBITOR TREATMENT: WEEK 52 POOLED RESULTS FROM TWO PHASE 3 STUDIESOrg: UCB Pharma, Ruhr-University Bochum, Herne, University of Leeds,
Abstract
BIMEKIZUMAB SHOWS SUSTAINED LONG-TERM IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN ANKYLOSING SPONDYLITIS: 3-YEAR RESULTS FROM A PHASE 2B STUDYOrg: Ruhr-University Bochum, Herne, Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Rheumatology, Bochum, Herne, Netherlands, Hôpital Cochin, Norfolk and Norwich University Hospital NHS Trust, The Royal National Hospital for Rheumatic Diseases,